Health Practitioner Attitudes to Psychosocial Treatments in ADHD: Impact of Country, Age, Profession, and Beliefs

IF 1.3 Q3 EDUCATION, SPECIAL

Advances in Neurodevelopmental Disorders Pub Date : 2024-06-26 DOI:10.1007/s41252-024-00409-x

Haffiezhah An-Nadiah Azlan, Paul G. Overton, Eleanor J. Dommett

{"title":"Health Practitioner Attitudes to Psychosocial Treatments in ADHD: Impact of Country, Age, Profession, and Beliefs","authors":"Haffiezhah An-Nadiah Azlan, Paul G. Overton, Eleanor J. Dommett","doi":"10.1007/s41252-024-00409-x","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Attention deficit hyperactivity disorder (ADHD) affects around 7% of children/adolescents and 3% of adults. Treatment guidelines propose a combination of pharmacological and non-pharmacological approaches. Despite this, research has focused on the use of medication, including how this varies between countries, with differences found between high-income countries (HIC) and low- and middle-income countries (LMIC). Studies have also identified that the role of practitioners is critical with their clinical ambivalence around ADHD impacting treatment. The present study aimed to examine the views of practitioners towards psychosocial treatments for ADHD in the UK (HIC) and Malaysia (LMIC).</p><h3>Methods</h3><p>Data was collected from health practitioners in the UK and Malaysia using an online survey to assess (i) demographics and employment characteristics, (ii) practitioners’ attitudes to psychosocial treatments for ADHD, and (iii) practitioners’ beliefs about ADHD.</p><h3>Results</h3><p>Respondents in Malaysia held more positive attitudes towards psychosocial interventions, despite having similar beliefs about the condition. Furthermore, attitude to psychosocial interventions was predicted by age of the practitioner, their qualification, and belief in ADHD as a real condition with biological markers.</p><h3>Conclusions</h3><p>This study has revealed some cross-cultural differences in attitudes towards non-pharmacological treatment for ADHD and provides a starting point for future research to move beyond examination of decision-making for pharmacological treatments only.</p></div>","PeriodicalId":36163,"journal":{"name":"Advances in Neurodevelopmental Disorders","volume":"9 1","pages":"157 - 167"},"PeriodicalIF":1.3000,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s41252-024-00409-x.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Neurodevelopmental Disorders","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1007/s41252-024-00409-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"EDUCATION, SPECIAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

Attention deficit hyperactivity disorder (ADHD) affects around 7% of children/adolescents and 3% of adults. Treatment guidelines propose a combination of pharmacological and non-pharmacological approaches. Despite this, research has focused on the use of medication, including how this varies between countries, with differences found between high-income countries (HIC) and low- and middle-income countries (LMIC). Studies have also identified that the role of practitioners is critical with their clinical ambivalence around ADHD impacting treatment. The present study aimed to examine the views of practitioners towards psychosocial treatments for ADHD in the UK (HIC) and Malaysia (LMIC).

Methods

Data was collected from health practitioners in the UK and Malaysia using an online survey to assess (i) demographics and employment characteristics, (ii) practitioners’ attitudes to psychosocial treatments for ADHD, and (iii) practitioners’ beliefs about ADHD.

Results

Respondents in Malaysia held more positive attitudes towards psychosocial interventions, despite having similar beliefs about the condition. Furthermore, attitude to psychosocial interventions was predicted by age of the practitioner, their qualification, and belief in ADHD as a real condition with biological markers.

Conclusions

This study has revealed some cross-cultural differences in attitudes towards non-pharmacological treatment for ADHD and provides a starting point for future research to move beyond examination of decision-making for pharmacological treatments only.

查看原文本刊更多论文

健康从业者对ADHD心理治疗的态度：国家、年龄、职业和信仰的影响

目的注意缺陷多动障碍（ADHD）影响约7%的儿童/青少年和3%的成年人。治疗指南建议药物治疗和非药物治疗相结合。尽管如此，研究的重点是药物的使用，包括国家之间的差异，以及高收入国家（HIC）和低收入和中等收入国家（LMIC）之间的差异。研究还发现，从业人员的作用至关重要，因为他们对ADHD影响治疗的临床矛盾心理。本研究旨在调查从业人员对英国（HIC）和马来西亚（LMIC）多动症心理治疗的看法。方法通过在线调查从英国和马来西亚的卫生从业人员收集数据，以评估(i)人口统计和就业特征，（ii）从业人员对ADHD心理社会治疗的态度，以及（iii）从业人员对ADHD的信念。结果马来西亚的受访者对心理社会干预持更积极的态度，尽管他们对这种情况有类似的看法。此外，对心理社会干预的态度可以通过从业人员的年龄、资质和相信ADHD是一种具有生物学标记的真实疾病来预测。结论本研究揭示了对ADHD非药物治疗态度的一些跨文化差异，并为未来的研究提供了一个起点，使其超越仅对药物治疗决策的检查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Neurodevelopmental Disorders Social Sciences-Social Sciences (miscellaneous)

CiteScore

2.10

自引率

0.00%

发文量

期刊介绍： Advances in Neurodevelopmental Disorders publishes high-quality research in the broad area of neurodevelopmental disorders across the lifespan. Study participants may include individuals with:Intellectual and developmental disabilitiesGlobal developmental delayCommunication disordersLanguage disordersSpeech sound disordersChildhood-onset fluency disorders (e.g., stuttering)Social (e.g., pragmatic) communication disordersUnspecified communication disordersAutism spectrum disorder (ASD)Attention-deficit/hyperactivity disorder (ADHD), specified and unspecifiedSpecific learning disordersMotor disordersDevelopmental coordination disordersStereotypic movement disorderTic disorders, specified and unspecifiedOther neurodevelopmental disorders, specified and unspecifiedPapers may also include studies of participants with neurodegenerative disorders that lead to a decline in intellectual functioning, including Alzheimer’s disease, amyotrophic lateral sclerosis, Creutzfeldt-Jakob disease, vascular dementia, Lewy body dementia, frontotemporal dementia, corticobasal degeneration, Huntington’s disease, and progressive supranuclear palsy. The journal includes empirical, theoretical and review papers on a large variety of issues, populations, and domains, including but not limited to: diagnosis; incidence and prevalence; and educational, pharmacological, behavioral and cognitive behavioral, mindfulness, and psychosocial interventions across the life span. Animal models of basic research that inform the understanding and treatment of neurodevelopmental disorders are also welcomed. The journal is multidisciplinary and multi-theoretical, and encourages research from multiple specialties in the social sciences using quantitative and mixed-method research methodologies.